Immucell Corp (ICCC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2011 | 12-2010 | 09-2010 | 06-2010 | 03-2010 | |
| Sales | 1,556 | 1,123 | 874 | 1,079 | 1,312 |
| Cost of Goods | 688 | 554 | 510 | 450 | 570 |
| Gross Profit | 868 | 600 | 350 | 620 | 730 |
| Operating Expenses | 1,573 | 2,877 | 1,210 | 1,110 | 1,370 |
| Operating Income | -17 | -1,754 | -336 | -31 | -58 |
| Interest Expense | 0 | -8 | 8 | 0 | 0 |
| Other Income | -15 | 1,503 | -6 | 1 | -2 |
| Pre-tax Income | -32 | -243 | -350 | -30 | -60 |
| Income Tax | -8 | -109 | -150 | -30 | -10 |
| Net Income Continuous | -23 | 128 | -197 | -6 | -53 |
| Net Income | $-23 | $128 | $-197 | $-6 | $-53 |
| EPS Basic Total Ops | -0.01 | 0.04 | -0.07 | 0.00 | -0.02 |
| EPS Basic Continuous Ops | -0.01 | 0.04 | -0.07 | 0.00 | -0.02 |
| EPS Diluted Total Ops | -0.01 | 0.04 | -0.07 | 0.00 | -0.02 |
| EPS Diluted Continuous Ops | -0.01 | 0.04 | -0.07 | 0.00 | -0.02 |
| EBITDA(a) | $90 | $-1,644 | $-236 | $79 | $42 |